Cheng-Hock Toh: The Paradox of Hematology
Cheng-Hock Toh, Chair at National Blood Transfusion Committee,Professor of Medical Haematology at the University of Liverpool and Liverpool University Hospitals NHS Foundation Trust, shared on LinkedIn about a recent article he and Elisabeth Buggins co-authored, adding:
“The Visibility Problem
The Paradox of Hematology:
Because it is involved in everything, it is recognised in nothing.
- Abnormal bloods? ‘Ask haematology.’
- Clotting issue? ‘Ask haematology.’
- Transfusion problem? ‘Haematology should fix it.’
- Chemotherapy complication? ‘Haematology input needed.’
Yet haematology is rarely present in:
- digital design discussions
- workforce planning
- strategic NHS conversations
This invisibility has consequences — for safety, staffing and sustainability.
- We saw this clearly in transfusion practice.
- We see it in anticoagulation.
- We see it across cancer pathways.
When the discipline at the centre of medicine is treated as peripheral, systems begin to fail at the edges.”
Title: Transfusion safety continues to be compromised in the NHS
Authors: Cheng-Hock Toh, Elisabeth Buggins
Read the Full Article on The British Medical Journal.
Stay updated with Hemostasis Today.
-
Oct 15, 2026, 14:03JTH Research Recap Explores Occult Malignancy Screening in DVT
-
Oct 15, 2026, 13:52Thierry Peyrard: A Heartfelt Thank You Ahead of Blood 2026
-
Oct 15, 2026, 12:40Todd Keitz: DVT and PE Explained in Five Minutes
-
Oct 15, 2026, 12:35Bartosz Hudzik: Balancing Ischemic and Bleeding Risk After ACS and PCI
-
Oct 15, 2026, 12:25Violeta Jardin: Understanding Fibrinolytic Shutdown Beyond Conventional TEG
-
Oct 15, 2026, 11:28Iliana Chatzifragkou: How Does Haemophilia Affect Early Motor Development?
-
Oct 15, 2026, 11:14Sunil Bajaj: DVT Pumps Explained – Uses, Types, and Key Features
-
Oct 15, 2026, 10:57Surya Sundaravel: A New Review Explores the Diagnosis and Management of DVT
-
Oct 15, 2026, 10:39Dariush Mozaffarian: TMAO and Cardiovascular Risk Beyond Coronary Calcification